Sign inJoin waitlistJoin the waitlist

Alexa Kimball

DIRECTOR · Beth Israel Deaconess Medical Center

Credentials: · · · ·

History

Beth Israel Deaconess Medical Center
Present
Beth Israel Deaconess Medical Center
Present

Dermatology
1995–1998
Preliminary or Transitional Year
1994–1995
Yale Univ Sch of Med
1990–1994

Research

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled…
The Lancet · 2008 · 1,310 citations
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Journal of the American Academy of Dermatology · 2008 · 699 citations
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis:…
Journal of the American Academy of Dermatology · 2017 · Last of 8 authors · 697 citations

Kenneth Gordon
20 papers
Bruce Strober
16 papers
AB
Andrew Blauvelt
15 papers
MO
Martin Okun
15 papers
Afsaneh Alavi
13 papers
Kelsey Flood
13 papers · 13 as a resident
MM
Martin Menter
13 papers
Alice Gottlieb
12 papers
Nicole Golbari
12 papers · 2 as a resident
April Armstrong
10 papers · 2 as a fellow
KS
Kevin Savage
10 papers · 1 as a resident
RG
Ruby Gibson
10 papers · 8 as a resident

Clinical trials

Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
Principal investigator · Terminated · Phase 2
Beth Israel Deaconess Medical Center
2023–2025
Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
Principal investigator · Terminated · Phase 2
Beth Israel Deaconess Medical Center
2019–2021
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
Principal investigator · Unknown · Phase 3
NeoStrata Company, Inc.
2014–2015
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
2013–2015